Idiopathic thrombocytopenic purpura overview: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
The cause of ITP is thought to be related to chronic infections such as [[HIV]], [[hepatitis C]] and [[H. Pylori]].
The cause of ITP is thought to be related to chronic infections such as [[HIV]], [[hepatitis C]] and [[H. Pylori]].
==Epidemiology and Demographics==
==Epidemiology and Demographics==
The incidence of ITP is 50&ndash;100 new cases per million per year, with children accounting for half of that amount. The male:female ratio in the adult group is 1:1.2&ndash;1.7 (for children it is 1:1) and the median age of adults at the diagnosis is 56&ndash;60.<ref name="pmid15941913">{{cite journal |author=Cines DB, Bussel JB |title=How I treat idiopathic thrombocytopenic purpura (ITP) |journal=Blood |volume=106 |issue=7 |pages=2244-51 |year=2005 |pmid=15941913 |doi=10.1182/blood-2004-12-4598}}</ref>
The incidence of ITP is 5-10 new cases per 100,000 per year, with children accounting for half of that amount. The male:female ratio in the adult group is 1:1.2&ndash;1.7 (for children it is 1:1) and the median age of adults at the diagnosis is 56&ndash;60.<ref name="pmid15941913">{{cite journal |author=Cines DB, Bussel JB |title=How I treat idiopathic thrombocytopenic purpura (ITP) |journal=Blood |volume=106 |issue=7 |pages=2244-51 |year=2005 |pmid=15941913 |doi=10.1182/blood-2004-12-4598}}</ref>
 
==Diagnosis==
==Diagnosis==
===Other Diagnostic Studies===
===Other Diagnostic Studies===

Revision as of 15:26, 13 March 2013

Idiopathic thrombocytopenic purpura Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Idiopathic thrombocytopenic purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Idiopathic thrombocytopenic purpura overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Idiopathic thrombocytopenic purpura overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Idiopathic thrombocytopenic purpura overview

CDC on Idiopathic thrombocytopenic purpura overview

Idiopathic thrombocytopenic purpura overview in the news

Blogs on Idiopathic thrombocytopenic purpura overview

Directions to Hospitals Treating Idiopathic thrombocytopenic purpura

Risk calculators and risk factors for Idiopathic thrombocytopenic purpura overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Idiopathic thrombocytopenic purpura (ITP) is the condition of having a low platelet count (thrombocytopenia) of no known cause (idiopathic). As most causes appear to be related to antibodies against platelets, it is also known as immune thrombocytopenic purpura. Although most cases are asymptomatic, very low platelet counts can lead to a bleeding diathesis and purpura.

Causes

The cause of ITP is thought to be related to chronic infections such as HIV, hepatitis C and H. Pylori.

Epidemiology and Demographics

The incidence of ITP is 5-10 new cases per 100,000 per year, with children accounting for half of that amount. The male:female ratio in the adult group is 1:1.2–1.7 (for children it is 1:1) and the median age of adults at the diagnosis is 56–60.[1]

Diagnosis

Other Diagnostic Studies

A bone marrow examination may be performed on patients over the age of 60 and people who do not respond to treatment, or when the diagnosis is in doubt. The bone marrow biopsy in ITP can show increased (thought not always) megakaryocytes, bizarre giant platelets and platelet fragments. (Large platelets are often seen in the peripheral blood smear though this can be seen in other diseases.) When the spleen is removed it may show increased lymphatic nodularity.

Treatment

Radiation

Splenic radiation (RT) is usually given for steroid-resistant ITP. One to six weeks of 75-1370 cGy with or without concomittant post-RT steroids. Patients can respond for >1 year. It is a safe alternative for patients too old for splenectomy.

Primary Prevention

The causes and risk factors are unknown, except in children when it may be related to a viral infection. Prevention methods are unknown.

References

  1. Cines DB, Bussel JB (2005). "How I treat idiopathic thrombocytopenic purpura (ITP)". Blood. 106 (7): 2244–51. doi:10.1182/blood-2004-12-4598. PMID 15941913.

Template:WH Template:WS